AI
GEHC icon

Accredited Investors’s GE HealthCare GEHC Stock Holding History

Accredited Investors’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,935
Closed -$318K – 247
2025
Q1 		$318K Buy
3,935
+489
+14% +$42K 0.02% 169
2024
Q4 		$269K Sell
3,446
-81
-2% -$6.88K 0.02% 189
2024
Q3 		$331K Sell
3,527
-18
-0.5% -$1.51K 0.02% 169
2024
Q2 		$276K Buy
3,545
+1
+0% +$82 0.02% 172
2024
Q1 		$322K Buy
3,544
+1
+0% +$83 0.02% 156
2023
Q4 		$274K Sell
3,543
-48
-1% -$3.36K 0.02% 160
2023
Q3 		$244K Buy
3,591
+1
+0% +$73 0.02% 156
2023
Q2 		$292K Sell
3,590
-1
-0% -$80 0.02% 150
2023
Q1 		$295K Buy
+3,591
New +$256K 0.02% 149

Other funds holding GEHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Accredited Investors's GEHC Position: Q2 2025 in Review

Accredited Investors sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 3,935 shares — an estimated $318K sold.

Accredited Investors first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $331K in Q3 2024. 1,314 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

  • Accredited Investors reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
  • Accredited Investors sold 3,935 GE HealthCare shares in Q2 2025, an estimated $318K.
  • Accredited Investors first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Accredited Investors's GE HealthCare position peaked at $331K in Q3 2024.
  • 1,314 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on Accredited Investors's 13F filing for Q2 2025, filed 8 Aug 2025.